drugset / Trial / NCT01953315
Muscle Progenitor Cell Therapy for Urinary Incontinence
NaSingle-groupOpen-labelTreatment
Summary
This study is designed to evaluate the safety of muscle progenitor cells (MPCs) for the treatment of urinary incontinence due to incompetent outlet (bladder neck/urethra).
Timeline
- Start
- 2014-01
- Primary completion
- 2018-01
- Completion
- 2018-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Muscle Progenitor Cells | Cell therapy | — | Other |